NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026 · 7 Oct 2026, 01:11 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mangalam Drugs And Organics Limited · MANGALAM
✦ AI SummaryRegulatory
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
MANGALAM_07102026131053_SE35.pdf
View document text
Mangalam
Drugs and Organics Limited
Regd: fice R @u 9p 1a -m 2 B 2u -i 6ld 2i 6n 1g, 6 23 0rd 0 /F 6lo 3o 0r, 0 /2 83 79 8p 7. D ®‘ M 9o 1] -; 2R 2o -a 6d 26,
9Ne 0a 9r
G o. CP.
N0. LM 2u 4m 2b 3a 0i
140 90
2( P5
LC 116413
REF: MDOL/CS-SE/2026-27/035
October 07,2026
Listing Department
BSE Ltd
Listing Department
1t Floor, New Trade Wing, National Stock Exchange of India
Phiroze Jeejeebhoy Towers,
Limited
Dalal Street, Fort, “Exchange Plaza”, 5t Floor,
Mumbai - 400 001 Plot No. C-1, Block G,
Bandra - Kurla Complex,
Bandra(E), Mumbai - 400 051
Scrip Code: 532637
Symbol: MANGALAM
Subject: eIm n nd di e d Sm eptemi btm o er ri 30, 2m 026 im ci m lm ati n 2 u Ir m aj
Dear Sir/Madam,
2h LaI e 0in n mr 2dt ie 6 e twP r ea tim d or ts ” t h S i Ro ecf eti p gp hR tia ee esn g mttu Cs r bl o) a ea m r rt R p aei l 3ngo 0iun d ,al n7 a S 2c4 t h 0( i e a 2o5 6rn) .eCs eo , Trf rt 2 i at 0 fh n1 ie sc8 faS , ete reac su A r a gai s et m ni e re tens c o da e fen i td vd he efE d r x Coc ofmh r m a o ptn mi ag m ne e “ y MB t fo Uo o a F rtr Gi td m h e eo I f n pp tI l ein e rd ma ii es oa e d I( f fnD i rde n i op d a m o a s t Ji P utt r la io yc vr h a 0i e t 1e ,eds
We request your good office to kindly take the above certificate on record,
Thanking You,
Yours Faithfully,
For Mangalam Drugs & Organics Limited
Govardhan M. Dhoot
Managing Director
DIN:01240086
Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com
@ http://www.m. angalamdrugs.com
MUFG Intime India Private Limited
M U FG (Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 224918 6000
www.in.mpms.mufg.com
To, Date: 03-10-2026
The Compliance Officer/ Company Secretary
MANGALAM DRUGS & ORGANICS LIMITED
3RD FLOOR, RUPAM BUILDING
239, P.D. MELLO ROAD
MUMBAI
MUMBAI
PINCODE : 400001
Sub: Confirmation Certificate under Regulation 74(5) of Securies and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th September 2026, were confirmed (acceptedirejected) to the depositories by us and
that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are
listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmedirejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
Apartof MUFG Corporate Markets, a division of MUFG Pension & Market Services